AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
27min chapter
Episode 46. Updates in Myeloma MRD with Dr. Ben Derman and Dr. Manni Mohyuddin
Blood Cancer Talks
Understanding Minimal Residual Disease (MRD) in Myeloma Treatment
The chapter explores the complexities of measuring minimal residual disease (MRD) in myeloma and its significance in treatment decisions. It discusses the debate around using MRD negativity as a primary treatment goal, its limitations as a predictor of overall survival, and its potential impact on accelerating drug approvals. The speakers also analyze the challenges and considerations in aiming for MRD negativity, including the balance between treatment outcomes, patient care, and clinical trial standards.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode